Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) traded up 7.2% on Tuesday . The company traded as high as $78.14 and last traded at $78.14. Approximately 20 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 1,490 shares. The stock had previously closed at $72.9110.
Cochlear Price Performance
The business has a 50-day simple moving average of $78.79 and a two-hundred day simple moving average of $132.46.
Cochlear Company Profile
Cochlear (OTCMKTS:CHEOF) is a global medical device company specializing in implantable hearing solutions. The company researches, develops, manufactures and markets cochlear implants, bone conduction hearing devices and acoustic implants designed to improve hearing outcomes for individuals with varying degrees of hearing loss. Cochlear’s product portfolio includes implant processors, electrode arrays and sound processor accessories, supported by proprietary digital signal processing technologies.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear has grown into a multi-national organization with operations in North America, Europe, Asia Pacific and Latin America.
Read More
- Five stocks we like better than Cochlear
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
